Showing results (251-260 of 1,831) with videos related to

Sort By:
Pageof 184
ESMO Open|August 2, 2017
Retrospective analysis of HER2 therapy interruption in patients responding to the treatment in metastatic HER2+ breast cancerTiina Moilanen, Susanna Mustanoja, Peeter Karihtala, et al.
ESMO Open|October 26, 2017
Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literatureMyrto Kastrisiou, Fereniki-Lida Kostadima, Aristides Kefas, et al.
ESMO Open|November 7, 2017
Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinomaPhilippe Merle, Philippe Camus, Armand Abergel, et al.
ESMO Open|August 30, 2017
Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacyAndrea Milani, Rebecca Kristeleit, Mary McCormack, et al.
ESMO Open|August 30, 2017
The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approachesPanagiota Economopoulou, Ioannis Kotsantis, Amanda Psyrri
ESMO Open|August 30, 2017
Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantationAtul Sharma, Tvsvgk Tilak, Sameer Bakhshi, et al.
ESMO Open|August 30, 2017
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohortHoward A Burris, Suzanne Bakewell, Johanna C Bendell, et al.
ESMO Open|August 30, 2017
Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFRHitomi Sakai, Hidetoshi Hayashi, Tsutomu Iwasa, et al.
ESMO Open|January 19, 2018
TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinomaCharlotte Leduc, Julien Adam, Emilie Louvet, et al.
ESMO Open|December 7, 2017
Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targetsPedro Nazareth Aguiar, Ramon Andrade De Mello, Carmelia Maria Noia Barreto, et al.
Pageof 184